Metabolic balance in colorectal cancer is maintained by optimal Wnt signaling levels

por Imkeller, Katharina, Ambrosi, Giulia, Klemm, Nancy, Claveras Cabezudo, Ainara, Henkel, Luisa, Huber, Wolfgang, Boutros, Michael
Publicado 2022

TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms

por Schimmer, Roman R., Kovtonyuk, Larisa V., Klemm, Nancy, Fullin, Jonas, Stolz, Sebastian M., Mueller, Jan, Caiado, Francisco, Kurppa, Kari J., Ebert, Benjamin L., Manz, Markus G., Boettcher, Steffen
Publicado 2022